Bruker [BRKR] vs Bio-Rad Laboratories [BIO] Detailed Stock Comparison

Bruker Corporation

NASDAQ
Loading...

Bio-Rad Laboratories Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Bruker Corporation wins in 6 metrics, Bio-Rad Laboratories Inc. wins in 14 metrics, with 0 ties. Bio-Rad Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bruker Corporation Bio-Rad Laboratories Inc. Better
P/E Ratio (TTM) 74.88 10.98 Bio-Rad Laboratories Inc.
Price-to-Book Ratio 2.24 1.11 Bio-Rad Laboratories Inc.
Debt-to-Equity Ratio 81.38 18.58 Bio-Rad Laboratories Inc.
PEG Ratio 6.74 -0.05 Bruker Corporation
EV/EBITDA 14.63 18.75 Bruker Corporation
Profit Margin (TTM) -0.25% 29.42% Bio-Rad Laboratories Inc.
Operating Margin (TTM) 6.58% 8.87% Bio-Rad Laboratories Inc.
EBITDA Margin (TTM) 6.58% 8.87% Bio-Rad Laboratories Inc.
Return on Equity -0.38% 10.84% Bio-Rad Laboratories Inc.
Return on Assets (TTM) 2.90% 1.67% Bruker Corporation
Free Cash Flow (TTM) $13.90M $374.60M Bio-Rad Laboratories Inc.
Dividend Yield 0.65% N/A N/A
1-Year Return 41.59% 26.01% Bruker Corporation
Price-to-Sales Ratio (TTM) 1.60 3.20 Bruker Corporation
Enterprise Value $7.31B $8.09B Bio-Rad Laboratories Inc.
EV/Revenue Ratio 2.13 3.13 Bruker Corporation
Gross Profit Margin (TTM) 45.97% 49.80% Bio-Rad Laboratories Inc.
Revenue per Share (TTM) $23 $95 Bio-Rad Laboratories Inc.
Earnings per Share (Diluted) $-0.15 $27.85 Bio-Rad Laboratories Inc.
Beta (Stock Volatility) 1.20 1.16 Bio-Rad Laboratories Inc.
Short % of Float 17.68% 0.00% Bio-Rad Laboratories Inc.

Bruker Corporation vs Bio-Rad Laboratories Inc. Stock Performance Analysis

Loading Price Chart...

BRKR
BIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bruker Corporation4.43%0.66%32.07%72.86%24.00%17.71%
Bio-Rad Laboratories Inc.1.17%-0.70%16.87%10.73%-6.05%-5.24%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bruker Corporation41.59%-28.15%-24.98%125.58%203.81%984.60%
Bio-Rad Laboratories Inc.26.01%-24.07%-54.09%102.91%143.91%328.31%

Performance & Financial Health Analysis: Bruker Corporation vs Bio-Rad Laboratories Inc.

MetricBRKRBIO
Market Information
Market Cap i$5.56B$7.60B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i2,049,283239,625
90 Day Avg. Volume i2,108,108284,785
Last Close$56.63$289.28
52 Week Range$28.53 - $64.54$222.80 - $343.12
% from 52W High-12.26%-15.69%
All-Time High$94.86 (Mar 18, 2024)$832.70 (Aug 30, 2021)
% from All-Time High-40.30%-65.26%
Growth Metrics
Quarterly Revenue Growth0.00%0.04%
Quarterly Earnings Growth0.90%0.04%
Financial Health
Profit Margin (TTM) i0.00%0.29%
Operating Margin (TTM) i0.07%0.09%
Return on Equity (TTM) i0.00%0.11%
Debt to Equity (MRQ) i81.3818.58
Cash & Liquidity
Book Value per Share (MRQ)$16.15$276.16
Cash per Share (MRQ)$1.96$57.08
Operating Cash Flow (TTM) i$134.10M$532.20M
Levered Free Cash Flow (TTM) i$216.96M$256.55M
Dividends
Last 12-Month Dividend Yield i0.65%N/A
Last 12-Month Dividend i$0.25N/A

Valuation & Enterprise Metrics Analysis: Bruker Corporation vs Bio-Rad Laboratories Inc.

MetricBRKR (Apr 26, 2026)BIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i74.8810.98
Forward P/E i15.0126.94
PEG Ratio i6.74-0.05
Price to Sales (TTM) i1.603.20
Price to Book (MRQ) i2.241.11
Market Capitalization
Market Capitalization i$5.56B$7.60B
Enterprise Value i$7.31B$8.09B
Enterprise Value Metrics
Enterprise to Revenue i2.133.13
Enterprise to EBITDA i14.6318.75
Risk & Other Metrics
Beta i1.201.16
Book Value per Share (MRQ) i$16.15$276.16

Financial Statements Comparison: Bruker Corporation vs Bio-Rad Laboratories Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBRKR (2025)BIO (2025)
Revenue/Sales i3.44B2.58B
Cost of Goods Sold i1.86B1.24B
COGS % of Revenue i54.1%48.1%
Gross Profit i1.58B1.34B
Gross Margin i45.9%51.9%
Research & Development i395.20M275.60M
Operating Income (EBIT) i236.00M218.60M
Operating Margin i6.9%8.5%
EBITDA i456.80M480.70M
EBITDA Margin i13.3%18.6%
Pre-Tax Income i22.00M995.50M
Pre-Tax Income % of Revenue i0.6%38.5%
Income Tax i29.30M235.60M
Income Tax % of Revenue i0.9%9.1%
Net Income (Profit) i-8.30M759.90M
Profit Margin i-0.2%29.4%

Balance Sheet & Liquidity Metrics

MetricBRKR (2025)BIO (2025)
Cash & Equivalents i298.80M529.80M
Total Current Assets i2.21B2.91B
Total Current Assets % of Revenue i64.4%112.5%
Total Current Liabilities i1.28B517.00M
Total Current Liabilities % of Revenue i37.2%20.0%
Long-Term Debt i1.99B1.35B
Long-Term Debt % of Revenue i57.9%52.2%
Total Shareholders Equity i2.51B7.45B
Retained Earnings i2.36B8.18B
Retained Earnings % of Revenue i68.7%316.5%
Property, Plant & Equipment i165.80M1.49B

Cash Flow Statement Comparison

MetricBRKR (2025)BIO (2025)
Operating Cash Flow i82.50M1.25B
Operating Cash Flow % of Revenue i2.4%48.4%
Capital Expenditures i-90.80M-157.50M
Free Cash Flow i13.90M374.60M
FCF Margin i0.4%14.5%
Debt Repayment i-1.25B-500,000
Common Stock Repurchase i-10.00M-295.50M

Short Interest & Institutional Ownership Analysis

MetricBRKRBIO
Shares Short i12.53M26
Short Ratio i6.300.00
Short % of Float i17.68%0.00%
Shares Outstanding i152.14M26.99M
Float Shares i103.57M21.13M
% Held by Insiders i26.95%16.20%
% Held by Institutions i91.32%91.50%
% Held by Public i-18.27%-7.70%

Dividend Analysis & Yield Comparison: Bruker Corporation vs Bio-Rad Laboratories Inc.

MetricBRKRBIO
Last 12-Month Dividend i$0.25N/A
Last 12-Month Dividend Yield i0.65%N/A
3-Year Avg Annual Dividend i$0.20N/A
3-Year Avg Dividend Yield i0.10%N/A
3-Year Total Dividends i$0.60N/A
Ex-Dividend DateMar 23, 2026N/A